Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Supplementation by ketosteril

Phase 2

CCentre Hospitalier le Mans

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

HaemodialysisNot yet recruiting

HaemodialysisPhase 2

Not yet recruiting

Timeline

Expected Milestones

Q3 2030

Phase 2Not yet recruiting

Haemodialysis

NCT07699627

Clinical

Trials by Indication[1]

Haemodialysis1 trial

INCREDIBLE: INCREmental DIalysis and Diet for a Better Life Experience; Clinical Relevance of an "add-on" Ketosteril Supplementation on Incremental Haemodialysis Period in Incident Haemodialysis Patients. An Exploratory Randomized Controlled Trial

Not yet recruiting·CCentre Hospitalier le Mans·Phase 2·NCT07699627·70 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Supplementation by ketosteril. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Supplementation by ketosteril. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Centre Hospitalier le Mans company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 2[1]
Company: CCentre Hospitalier le Mans

Related News